what is CJC 1295?

CJC-1295 is a long-acting analog of GH-releasing hormone (GHRH), which has shown promise in stimulating the secretion of growth hormone (GH) and insulin-like growth factor I (IGF-I) in healthy adults. In a recent study, subjects were injected with CJC-1295 twice daily for 28 days, and GH and IGF-I levels were measured at baseline and at days 14 and 28. The results showed that CJC-1295 was safe and well tolerated, with no serious adverse effects reported. Moreover, there was a significant increase in GH and IGF-I levels in the subjects receiving CJC-1295, compared to those receiving a placebo. These findings suggest that CJC-1295 may be an effective way to stimulate GH and IGF-I secretion in healthy adults, with potential benefits for muscle growth, strength, and recovery from exercise.